Clik here to view.
Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific...
Each week in The Pharmcast, we talk with top industry experts from our network or beyond about hot industry topics, leadership, and the path to success. This week in The Pharmcast, we catch up with...
View ArticleClik here to view.
Clik here to view.
From Big Pharma to Biotech C-Suite: Industry and Career Insights from Dr....
Ac This week on The Pharmcast, we talk with Dr. June Almenoff, former President, Chief Medical Officer and Board Member of a biotech, which was recently acquired in 2014 by Actavis for $1.2...
View ArticleClik here to view.
Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr....
This week on The Pharmcast, we talk with Dr. Don Therasse, former VP of Global Patient Safety for Eli Lilly & Company, and current Strategic Advisor for YourEncore.With over 26 years of experience...
View ArticleClik here to view.
FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The...
This week on The Pharmcast, we explore best practices and common pitfalls in FDA 483 Responses. In 2015, there were an average of 175 inspections and 10 warning letters issued per month by the Center...
View ArticleClik here to view.
No Surprises: Improving Medical Devices Due Diligence (Ep. 9 on The Pharmcast)
This week on The Pharmcast, we discuss areas often overlooked in due diligence efforts that can lead to expensive or even show-stopper surprises once the acquisition is complete and later development...
View ArticleClik here to view.
Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The...
This week on The Pharmcast, we turn our attention to the topic of rare disease, and more specifically: how to engage and educate rare disease patients to advance development. It's estimated that nearly...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Executive Briefing: EU Medical Device Regulation | 5 Ways EU MDR Will Impact...
The European Union has agreed on a new Medical Device Regulation meant to improve patient safety and data transparency. The regulation is extensive and impactful – it touches many functions within the...
View ArticleClik here to view.
Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim...
We are at a time of great change and transition in the FDA. The sitting FDA chief stepped down, just when the 21st Century Cures Act passed into law; PDUFA 6 is up for renewal this year; and the new...
View ArticleClik here to view.
Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of...
On this week's episode of The Pharmcast, we explore the key elements of an effective regulatory strategy and how to drive value to patient and shareholders by working with the FDA. We also cover common...
View ArticleClik here to view.
The Future is Here: Using Big Data and Artificial Intelligence in Oncology...
On this week's episode of The Pharmcast, we talk with YourEncore Expert, Philippe Barzin, on the future of big data and artificial intelligence in oncology. Based off Philippe's article, Artificial...
View ArticleClik here to view.
7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)
On this episode of The Pharmcast, Heidi Youngkin shares seven best practices for successful biologic launch communication.When it costs over $2.5B dollars to develop a drug, according to the most...
View ArticleClik here to view.
Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron...
This week on The Pharmcast, we tackle one of the hottest topics in the life sciences and healthcare industry: digital health. The promise of digital health is enticing, and a logical evolution of the...
View ArticleClik here to view.
YourEncore Announces Addition of Michelle DeJonge and Dr. James Wood as...
INDIANAPOLIS, IN--YourEncore (www.yourencore.com), a company that helps firms in the life sciences, consumer products and food sciences industries solve complex innovation, compliance and productivity...
View ArticleClik here to view.
The Frontiers of Rare Disease Development: Advances in Regulatory Science...
This week on The Pharmcast, we catch up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project Muscular Dystrophy, a...
View ArticleClik here to view.
State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The...
In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of the Industry: U.S. Regulatory Policy Overview. Parthenon-EY and YourEncore recently conducted a nationwide...
View ArticleClik here to view.
Ten Tips for Enterprise Technology Adoption in Pharma
The RFP processes are robust, the ROI models are compelling, the software is best of breed, and the expectations are high. So, why do so many software deployment programs in Pharma fail to deliver...
View ArticleClik here to view.
How Blockchain is Revolutionizing the World and Changing Healthcare as We...
In this episode of The Pharmcast, we join YourEncore Expert, Darryl Glover, to discuss one of the hottest technologies on the market today: blockchain.We've heard some people say that if the internet...
View Article